Biolife solutions to report fourth quarter and full year 2024 financial results and business update on march 3, 2025

Bothell, wash. , feb. 20, 2025 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") market, today announced the 2024 fourth quarter and full year financial results will be released on march 3, 2025 pre-market.
BLFS Ratings Summary
BLFS Quant Ranking